This report contains market size and forecasts of Companion Animal Speciality Drugs in global, including the following market information:
- Global Companion Animal Speciality Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Companion Animal Speciality Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Companion Animal Speciality Drugs companies in 2021 (%)
The global Companion Animal Speciality Drugs market was valued at 12890 million in 2021 and is projected to reach US$ 17370 million by 2028, at a CAGR of 4.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Animal Speciality Drugs include Zoetis, Merck, Bayer, Elanco, Boehringer Ingelheim and Ceva Sante Animale, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Companion Animal Speciality Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Animal Speciality Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Companion Animal Speciality Drugs Market Segment Percentages, by Type, 2021 (%)
- Antibiotics
- Anti-inflammatory Drugs
- Parasiticides
- Heartworm
- Nutritional Products
- Anti-Obesity Drugs
- Skin Care Products
- Vaccines
Global Companion Animal Speciality Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Companion Animal Speciality Drugs Market Segment Percentages, by Application, 2021 (%)
Global Companion Animal Speciality Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Companion Animal Speciality Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Companion Animal Speciality Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Companion Animal Speciality Drugs revenues share in global market, 2021 (%)
- Key companies Companion Animal Speciality Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
- Key companies Companion Animal Speciality Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Zoetis
- Merck
- Bayer
- Elanco
- Boehringer Ingelheim
- Ceva Sante Animale
